GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Sipai Health Technology Co Ltd (HKSE:00314) » Definitions » Cash Flow from Financing

Sipai Health Technology Co (HKSE:00314) Cash Flow from Financing : HK$-132 Mil (TTM As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Sipai Health Technology Co Cash Flow from Financing?

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the six months ended in Dec. 2023, Sipai Health Technology Co paid HK$73 Mil more to buy back shares than it received from issuing new shares. It received HK$0 Mil from issuing more debt. It paid HK$0 Mil more to buy back preferred shares than it received from issuing preferred shares. It received HK$0 Mil from paying cash dividends to shareholders. It spent HK$98 Mil on other financial activities. In all, Sipai Health Technology Co spent HK$94 Mil on financial activities for the six months ended in Dec. 2023.


Sipai Health Technology Co Cash Flow from Financing Historical Data

The historical data trend for Sipai Health Technology Co's Cash Flow from Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sipai Health Technology Co Cash Flow from Financing Chart

Sipai Health Technology Co Annual Data
Trend Dec21 Dec22 Dec23
Cash Flow from Financing
684.84 91.22 -131.85

Sipai Health Technology Co Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23
Cash Flow from Financing - -16.03 106.50 -21.10 -110.75

Sipai Health Technology Co Cash Flow from Financing Calculation

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

Sipai Health Technology Co's Cash from Financing for the fiscal year that ended in Dec. 2023 is calculated as:

Sipai Health Technology Co's Cash from Financing for the quarter that ended in Dec. 2023 is:


Cash Flow from Financing for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-132 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sipai Health Technology Co  (HKSE:00314) Cash Flow from Financing Explanation

Cash from financing contains six items:

1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

Sipai Health Technology Co's issuance of stock for the six months ended in Dec. 2023 was HK$5 Mil.

2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.

Sipai Health Technology Co's repurchase of stock for the six months ended in Dec. 2023 was HK$0 Mil.

3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Sipai Health Technology Co's net issuance of debt for the six months ended in Dec. 2023 was HK$0 Mil. Sipai Health Technology Co received HK$0 Mil from issuing more debt.

4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Sipai Health Technology Co's net issuance of preferred for the six months ended in Dec. 2023 was HK$0 Mil. Sipai Health Technology Co paid HK$0 Mil more to buy back preferred shares than it received from issuing preferred shares.

5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Sipai Health Technology Co's cash flow for dividends for the six months ended in Dec. 2023 was HK$0 Mil. Sipai Health Technology Co received HK$0 Mil from paying cash dividends to shareholders.

6. Other Financing:
Money spent or earned by company from other financial activities.

Sipai Health Technology Co's other financing for the six months ended in Dec. 2023 was HK$-98 Mil. Sipai Health Technology Co spent HK$98 Mil on other financial activities.


Sipai Health Technology Co Cash Flow from Financing Related Terms

Thank you for viewing the detailed overview of Sipai Health Technology Co's Cash Flow from Financing provided by GuruFocus.com. Please click on the following links to see related term pages.


Sipai Health Technology Co (HKSE:00314) Business Description

Traded in Other Exchanges
Address
No. 1888, Caoyang Road, 7/F, Building 3, Xingguangyao Plaza, Putuo District, Shanghai, CHN
Sipai Health Technology Co Ltd is a medical technology and health management company in China. It has three reportable operating segments: Specialty Pharmacy Business - operation and distribution of specialty pharmacy stores and pharmaceutical products; Physician Research Assistance Business - offering pharmaceutical companies and other clinical trial institutions site management organization services; Health Insurance Services Business - rendering insurance brokerage services to insurance companies. The company generates key revenue from Specialty Pharmacy Business. Almost all of the company's revenues were derived from operations in the PRC.
Executives
Chang Jimmy Ching-hsin 2201 Interest of corporation controlled by you
Jeneration Group Limited 2201 Interest of corporation controlled by you
Leung Catherine Ho Yan 2202 Interest of your spouse
Purple Panther 2201 Interest of corporation controlled by you
Ma Xuguang 2501 Other
Li Ji 2501 Other
Wise Approach Investments Limited 2101 Beneficial owner
Ark Trust (hong Kong) Limited 2301 Trustee
Jpmorgan Chase & Co. 2502 Approved lending agent
Lucky Seven Healthcare Co., Ltd. 2101 Beneficial owner
Simul International Holdings Limited 2201 Interest of corporation controlled by you
Oriental Power Holdings Limited
Nasturtium Investment Limited
Tencent Mobility Limited
Tencent Holdings Limited

Sipai Health Technology Co (HKSE:00314) Headlines

No Headlines